Pakistan: Recent research published in the Cureus Journal has identified the platelet-to-lymphocyte ratio (PLR) as a reliable ...

Over the past decade, immunotherapy has revolutionized cancer treatment, improving the chance for cure and survival even for poor-prognosis tumors. Immune ...

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

LIKE most of us, when Zee Valentina began feeling more tired than normal, she – and even her doctors – dismissed it as ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

An evaluation of nearly 19,000 patients with metastatic colorectal cancer supported clinical trial data that immunotherapy ...

Melanoma is one of the most aggressive forms of skin cancer, arising from pigment-producing cells called melanocytes. While ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

In addition to the receptor used to locate tumor cells, this treatment adds an element that further enhances the immune ...